Louise Rodino Klapac, Ph.D
About Louise Rodino Klapac, Ph.D
Louise R. Rodino-Klapac PhD Title
Louise R. Rodino-Klapac, PhD, holds the positions of Executive Vice President, Head of R&D, and Chief Scientific Officer. These roles highlight her leadership in driving research and development initiatives within the organization.
Louise R. Rodino-Klapac Molecular Genetics and Gene Therapy Expertise
Louise R. Rodino-Klapac, PhD, is renowned for her contributions to molecular genetics and gene therapy. Her work in these fields has established her as a notable figure, particularly in the area of developing genetic treatments for muscular dystrophies.
Louise R. Rodino-Klapac Investigational Limb-Girdle Muscular Dystrophy Programs
Dr. Rodino-Klapac's pioneering research serves as the foundation for five investigational programs targeting limb-girdle muscular dystrophy. These programs signify substantial progress in finding effective treatments for this group of genetic disorders.
Louise R. Rodino-Klapac Gene Editing Innovation at Sarepta
As a leader in gene editing therapies, Louise R. Rodino-Klapac is at the forefront of development at Sarepta's Gene Editing Innovation Center. Her role involves advancing the scientific and therapeutic applications of gene editing technology.
Louise R. Rodino-Klapac Collaboration with Charlie Gersbach PhD
Dr. Rodino-Klapac is collaborating with Charlie Gersbach, PhD, at the Gene Editing Innovation Center to develop therapies for Duchenne muscular dystrophy. This collaboration aims to leverage gene editing techniques to create effective treatments for this severe muscle disorder.